Biotech news
Americas
As antibodies cement their status as a major therapeutic class, securing robust IP protection has grown increasingly difficult. With heightened scrutiny on enablement and written description requirements, this panel unpacks strategies for building resilient antibody portfolios in a challenging global landscape. 16 May 2026
Unified Patent Court
Are life sciences cases gaining momentum in the new Unified Patent Court? This session provides a critical update on the UPC's evolving jurisprudence, looking at emerging legal tests and the specific challenges of preliminary injunctions for life sciences products. 14 May 2026
Americas
PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices. 13 May 2026
Americas
The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion. 12 May 2026
Europe
The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty. 30 April 2026
Americas
Pharma group strikes an all-cash transaction, combining a portfolio expansion with a contingent payment linked to a dispute over a $5 billion drug 28 April 2026
Americas
BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule. 28 April 2026
Americas
Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges. 22 April 2026
Americas
A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court. 17 April 2026
Americas
The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations. 16 April 2026